• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

DexCom, Inc.

NASDAQ:DXCM

$10.79 $0.30 (2.86%)

REAL-TIME: Last trade at

DexCom Misses on EPS, Losses Mount - Analyst Blog

DexCom Misses on EPS, Losses Mount

DexCom posts higher revenues, lower earnings

Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Gen 4 in FDA's Hands Now

DexCom, Inc. (DXCM) Misses Q1 EPS by 2c

DexCom reports Q1 EPS (21c) , consensus (19c)

Dexcom to Present at the Deutsche Bank 37th Annual Healthcare Conference

Dexcom Schedules First Quarter 2012 Earnings Release and Conference Call for May 2, 2012

JDRF Announces Research Collaboration With Dexcom, Inc. To Develop

JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies

Avondale Partners Starts DexCom (DXCM) at Market Outperform

DexCom initiated with an Outperform at Avondale (pre-open)

DexCom shares should be bought on weakness, says Stephens

Piper Jaffray's medtech research team holds a conference call

Leerink Swann Starts DexCom (DXCM) at Market Perform; Positive Long-Term, But Some Near-Term Hurdles

DexCom initiated with a Market Perform at Leerink

DexCom files to sell 384K shares of common stock for holders

Dexcom to Present at the Barclays Capital Global Healthcare Conference

Jefferies Raises Price Target on DexCom (DXCM) 40% After Q4 Results

DexCom's EPS Misses, Sales Beat - Analyst Blog

DexCom's EPS Misses, Sales Beat

Dexcom (DXCM) PT Raised To $13.50 By Brean Murray, 'Buy' Maintained

DexCom buys SweetSpot Diabetes Care for $4.5M

DexCom reports Q4 EPS (18c), consensus (17c)

DexCom, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results

DexCom, Inc. Announces Acquisition of SweetSpot Diabetes Care, Inc.

Dexcom Schedules Fourth Quarter and Full Year 2011 Earnings Release and Conference Call for February 23, 2012

DexCom and Tandem sign CGM development and commercialization agreement

DexCom, Tandem to Develop Insulin Pump

DexCom, Tandem Diabetes announce CGM development, commercialization agreement

DexCom and Tandem Diabetes Care Announce CGM Development and Commercialization Agreement

Piper Jaffray's medtech research team holds a conference call

Brean Murray Carret & Co. Starts DexCom (DXCM) at Buy; Sensing a Better Year Ahead

DexCom initiated with a Buy at Brean Murray

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

DexCom rises on 4Q guidance and 2012 outlook

McNicoll Lewis & Vlak Downgrades DexCom (DXCM) to Hold

DexCom Inc. (DXCM) CEO Terrance H Gregg sells 5,000 Shares

Dexcom To Present at the 30th Annual J.P. Morgan Healthcare Conference

5 Under-$10 Stocks Set to Soar

See More Articles...